send to a friend by email

JPH records net income of $1.60 million in Q1 2017

2017-05-02

According to the financial statements of Jerusalem Pharmaceuticals JPH for Q1 2017, Net profit after tax of the period reached 1,605,998 USD Compared with Net Loss after tax (398,776) USD for 2016.Total assets of the company reached 57,266,218 USD compared with total assets of 52,970,017 USD at the end of year 2016, a net increase of 8.11%.Total liabilities of the company reached 13,509,015 USD compared with total liabilities of 12,709,989 USD at the end of year 2016, a net increase of 6.28%. Net ownership equity of the company reached 43,757,203 USD (Including Non-Controlling Interests of 482,438 USD) compared with total owner equity of 40,260,028 USD (Including Non-Controlling Interests of 526,771 USD) at the end of year 2016, a net increase of 8.69%.